LIMNW • NASDAQ
Liminatus Pharma, Inc. Warrants
$0.07
Stock Details
| Market Cap | 1,945,422 |
|---|---|
| Day Change | 0.0284 (64.40%) |
| Volume | 2,000 |
| Avg Volume | 45,782.955 |
| Price Range | 0.0725-0.085 |
Overview
| Country | US |
|---|---|
| Sector | Healthcare |
| Industry | Biotechnology |
| Exchange | NASDAQ |
Company Profile
Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.
Financial Overview
| 52 Week High | 0.47 |
|---|---|
| 52 Week High Date | 2025-06-25 |
| 52 Week Low | 0.03 |
| 52 Week Low Date | 2026-01-28 |
| 10D Avg Trading Vol | 0.03838 |
| YTD Price Return Daily | 26 |
| MTD Price Return Daily | 47 |